𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer

✍ Scribed by J. J. Body; J. P. Sculier; N. Raymakers; M. Paesmans; P. Ravez; P. Libert; M. Richez; G. Dabouis; H. Lacroix; G. Bureau; J. Thiriaux; J. Lecomte; D. Brohée; P. Mommen; J. Frühling; J. Klastersky

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
422 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Availability of tumor-antigen 4 as a mar
Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs
✍ Naoko Mino; Atsushi Iio; Ken Hamamoto 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 1 views

The serum level of tumor-antigen 4 (TA-4) was measured in 401 patients with squamous cell carcinoma (SCC) of various organs (76 lung, 82 esophagus, and 234 head and neck). The mean serum level of TA-4 in patients with lung SCC was 3.6 times higher than that in healthy controls and even higher in the

Immunohistochemistry of the blood group
Immunohistochemistry of the blood group A, B, H isoantigens and Oxford Ca antigen as prognostic markers for stage IB squamous cell carcinoma of the cervix
✍ C. W. Alexander; Seng-jaw Soong; Hugh M. Shingleton; Hazel Gore; James A. Wilker 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB 👁 1 views

Currently, there is lack of a histologic classification of squamous cell carcinoma of the cervix that correlates significantly with patient survival. This study investigated the survival predictive value of two immunohistochemical markers, the blood group A,B,H isoantigens and the Oxford Ca antigen,

Decreased expression of CD80 is a marker
Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma
✍ Giovana R. Thomas; Zhong Chen; Malgorzata N. Oechsli; Fred J. Hendler; Carter Va 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 393 KB 👁 1 views

We established a new syngeneic murine model of oral squamous-cell carcinoma (SCC) to analyze the potential role of immune recognition determinants in the early development of oral cancer. In this study, we examined whether SCC that undergo transformation and development in the absence of specific im

Development of a new staging system for
Development of a new staging system for patients with recurrent laryngeal squamous cell carcinoma
✍ Peter D. Lacy; Jay F. Piccirillo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

The management of recurrent head and neck squamous cell carcinoma can be challenging to both physician and patient. This is due at least in part to the lack of an accurate and clinically applicable staging system for these patients. The purposes of this study were to examine the survival patterns of